IDD-3

IDD-3 Uses, Dosage, Side Effects, Food Interaction and all others data.

IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.

Table Of contents

• IDD-3
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	IDD-3
Generic	IDD-3
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in melanoma.

How IDD-3 works

IDD-3 is well tolerated with evidence of efficacy and induction of immune response in patients with progressive metastatic melanoma.

Innovators Monograph

You find simplified version here IDD-3